Models of Herpes Simplex Virus Latency
Viruses · 2024
DOI: 10.3390/v16050747 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Paige N Canova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA. Hauptthemen laut MEDLINE: Virus Latency, Herpes Simplex. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, NEI NIH HHS.
Abstract (Originalsprache)
Our current understanding of HSV latency is based on a variety of clinical observations, and in vivo, ex vivo, and in vitro model systems, each with unique advantages and drawbacks. The criteria for authentically modeling HSV latency include the ability to easily manipulate host genetics and biological pathways, as well as mimicking the immune response and viral pathogenesis in human infections. Although realistically modeling HSV latency is necessary when choosing a model, the cost, time requirement, ethical constraints, and reagent availability are also equally important. Presently, there remains a pressing need for in vivo models that more closely recapitulate human HSV infection. While the current in vivo, ex vivo, and in vitro models used to study HSV latency have limitations, they provide further insights that add to our understanding of latency. In vivo models have shed light on natural infection routes and the interplay between the host immune response and the virus during latency, while in vitro models have been invaluable in elucidating molecular pathways involved in latency. Below, we review the relative advantages and disadvantages of current HSV models and highlight insights gained through each.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA.
- Guarini School of Graduate and Advanced Studies at Dartmouth, Hanover, NH 03755, USA.
ORCID-Profile: Paige N Canova, Audra J Charron, David A Leib
Förderung
- NIH HHS
- NIAID NIH HHS
- NEI NIH HHS
- National Institutes of Health
Zitieren
APA
Canova, P. N., Charron, A. J., & Leib, D. A. (2024). Models of Herpes Simplex Virus Latency. Viruses. https://doi.org/10.3390/v16050747
Vancouver
Canova PN, Charron AJ, Leib DA. Models of Herpes Simplex Virus Latency. Viruses. 2024. doi:10.3390/v16050747
BibTeX
@article{Canova2024,
author = {Canova, Paige N and Charron, Audra J and Leib, David A},
title = {Models of Herpes Simplex Virus Latency},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16050747}
}
EUVIMED